共 12 条
[1]
Conforma-tional behavior and aggregation of alpha-synucleinin or-ganic solvens:Modeling the effects of membranes. Munishkina LA,Phelan C,Uversky VN. Biochemistry . 2003
[2]
Alpha-sy-nuclein cooperates with CSPalpha in preventing neuro-degeneration. Chandra S,Gallardo G,FernandezChacon R. Cell . 2005
[3]
Snaring the function of alpha-synuclein. Bonini NM,GiassonBI. Cell . 2005
[4]
Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization. Boesco DA,Fowler DM,Zhang Q. Nat Chem Biol . 2006
[5]
Acceleration of oli-gomerization,not fibrillization,is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson s disease:implications for pathogenesis and therapy. Conway KA,Lee SJ,Rochet JC. Proceedings of the National Academy of Sciences of the United States of America . 2000
[6]
Pathogenesis of Parkinson‘s disease:dopamine,vesicles and alpha-synuclein. Lotharius J,Brundin P. Nature Reviews Neuroscience . 2002
[7]
Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Giasson BI,Duda JE,Murray IV et al. Science . 2000
[8]
Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion. Gosavi N,Lee HJ,Lee JS,et al. Journal of Biological Chemistry . 2002
[9]
Is there a cause-and-effect relation- ship between alpha-synuclein fibrillization and Parkinson’s disease. Goldberg M S,Lansbury P T Jr. Nature Cell Biology . 2000
[10]
Dityrosine croaalink-ing promotesformation of stableα-synuclein polymers. Souza J M,Giasson BI,Chen Q. Biological Chemistry . 2000